Thema: US74276L1052
PRCT, US74276L1052
stocks-6377806_1920.jpg - Foto: THN
PROCEPT BioRobotics stock posts 18% Q3 revenue growth
PROCEPT BioRobotics stock reported stronger procedure activity and reaffirmed its 2026 outlook. Losses widened as investment spending increased.
ad-hoc-news.de, vor 56 Minuten
PRCT, US74276L1052
PROCEPT BioRobotics stock: MarketBeat cites a USD 25.50 ...
Second-quarter revenue rose 19.30 percent to USD 94.50 million. November 4, 2026 is the next results date for PROCEPT BioRobotics stock.
ad-hoc-news.de, 28.10.26 07:06 Uhr
PRCT, US74276L1052
PROCEPT BioRobotics sets November 4 results date: what it ...
Second-quarter revenue hit USD 94.50 million, up 19.30 percent year over year. The next report for PROCEPT BioRobotics stock is set for November 4, 2026.
ad-hoc-news.de, 21.10.26 00:18 Uhr
PRCT, US74276L1052
PROCEPT BioRobotics sets November 4 results date: what it ...
Revenue reached USD 94.50 million in the second quarter, up 19.30 percent year over year. A USD 20.00 target frames PROCEPT BioRobotics stock.
ad-hoc-news.de, 16.10.26 00:57 Uhr
PRCT, US74276L1052
PROCEPT BioRobotics stock gained 0.82 percent on October ...
The October 2 filing expanded the board from nine to ten members and appointed cardiac surgeon Michael Mack. Q2 revenue reached USD 94.5 million.
ad-hoc-news.de, 04.10.26 18:28 Uhr
Key, Dates
Key Dates for Procept BioRobotics Investors
